Thank you for your interest


Listen to the Podcast below or view a Transcript of the Podcast here



Engineering NK Cells for Enhanced Potency and Persistence

James B. Trager, PhD, Senior Vice President, Research and Development, Nkarta Therapeutics

Dr. James Trager shares a preview of his talk at the NK cell-based cancer immunotherapy meeting in Boston, discusses his next step in research and the vision of Nkarta in NK cell therapy development and what he’s looking forward to at this meeting such as the topics of inhibition of MIC protein shedding and NK cell metabolism.

 


cta-prelim-agenda

View By: